COVID-19 & Cancer | American Association for Cancer Research h3{ font-size: 19px; } .intro{ clear: left; margin-top: 26px; font-size: 1.1em } .aacrcontent { margin-bottom: 25px; font-size: 16px; } .aacrcontent .banner{ width: 100% margin: -20px; } .aacrcontent .banner-sm{ display: none; } .aacrcontent…
Scientific publishing is a cornerstone of disseminating knowledge. One caveat of scientific publishing is that at any one time it is biased toward certain topics…
Cancer Research | 84 | 8 | April 2024
This week: Tidbits from the American Association for Cancer Research (AACR) Annual Meeting, held April 5–10, in San Diego, CA, and other news. Soon, there…
Abstract: Researchers have successfully developed a liquid biopsy ovarian cancer assay. Known as DELPHI-protein, the assay uses AI to cross reference the presence of cell-free…
Abstract: New data from the PETRA clinical trial suggest that the PARP1 inhibitor saruparib induces durable responses in patients with HER-negative breast cancer. Researchers found…
Abstract: Since the discovery of WRN as a synthetic lethal target in microsatellite instability–high tumor types, the development space for drugs against this enzyme has…
Abstract: Trastuzumab deruxtecan became the first antibody–drug conjugate (ADC) to receive tissue-agnostic approval from the FDA, broadening its application to include any advanced solid tumor…
2023 Covers | Cancer Research | American Association for Cancer Research #aacr_embed_signup .aacr-field-group.input-group ul{list-style: none;} #aacr_embed_signup .aacr-field-group.input-group ul li{display: inline-block; width: fit-content; padding: 20px;} .inputsection…
Abstract. Non-small cell lung cancer (NSCLC) is associated with a 5-year survival rate of only 28%, however, when caught at an early stage, it can…
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will…
